Advances in the Development of Biomaterials for Endotoxin Adsorption in Sepsis

27Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Sepsis, a life-threatening and intractable disease without any specific treatment, is activated by endotoxin. Some attempts at removing endotoxin to treat sepsis from the blood circulation using different hemoperfusion cartridges have been proposed recently, but they have failed to reduce the mortality of severe septic patients. This review summarizes the latest advances in the development of endotoxin adsorbents. In particular, we highlight two critical parameters for endotoxin adsorbents when they are applied in blood purification: the dissociation constant and the maximum adsorption capacity. We also discuss potential challenges and research directions for the future development of endotoxin adsorbents.

Cite

CITATION STYLE

APA

Yang, Q., Li, Y., Tuohuti, P., Qin, Z., Zhang, Z., Zhao, W., & Su, B. (2021, July 30). Advances in the Development of Biomaterials for Endotoxin Adsorption in Sepsis. Frontiers in Bioengineering and Biotechnology. Frontiers Media S.A. https://doi.org/10.3389/fbioe.2021.699418

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free